Migraine Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must be located in the United States or Canada.
• You must currently be pregnant at the time of signing up.
• You must have been diagnosed with migraines by your doctor or healthcare provider.
• You must be willing to provide contact details for yourself, your doctor, and your baby's doctor (if applicable).
• You must give permission for your doctor(s) to share your medical information and your baby's medical information with the research team, if asked.
• You must fall into one of these three groups:
  • You have taken at least one dose of Ubrelvy during your pregnancy, and can provide details about how often you took it each trimester.
  • You have taken at least one dose of Qulipta during your pregnancy, and can provide the dates you started and stopped taking it.
  • You have never taken Ubrelvy or Qulipta, or you stopped taking Ubrelvy at least 2 days before becoming pregnant, or stopped Qulipta at least 5 days before becoming pregnant.

Who may not be able to join:

• You have taken any other migraine medications in the same drug family as Ubrelvy or Qulipta (called gepants), or certain migraine-prevention injections (called CGRP monoclonal antibodies), either shortly before conception or at any point during your pregnancy before enrolling (confirm with trial site).
• Your pregnancy has already ended and the outcome is already known — this study only accepts people who are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.